Preclinical imaging and translational animal models of cancer for accelerated clinical implementation of nanotechnologies and macromolecular agents

Article ID	Journal	Published Year	Pages	File Type
7862650	Journal of Controlled Release	2015	18 Pages	PDF

Keywords

VCAM-1 EMA FDA 18F-FLT GEMM 18F-FDG SCID TMT ICG DCE-MRI EGFR PDX VEGFR SPIO RFP PDGFR DW-MRI DSC-MRI MPIO 18F-labeled fluorodeoxyglucose %ID/g PLD ADC percent injected dose per gram NIR HER2 NOD DOX NOD SCID gamma NiS Patient-derived xenograft European Medicines agency Federal Drug Administration MRI Oncology Superparamagnetic iron oxide Indocyanine green SPECT Tesla EPR bioluminescence imaging Magnetic resonance imaging dynamic contrast enhanced magnetic resonance imaging Diffusion-weighted magnetic resonance imaging Preclinical imaging Multimodal imaging computed tomography Positron emission tomography SPIONs BLI PEGylated liposomal doxorubicin Doxorubicin Non-obese diabetic apparent diffusion coefficient Near infrared Metastasis Animal models Genetically engineered mouse models Superparamagnetic iron oxide nanoparticles Enhanced permeability and retention Herpes simplex virus type 1 thymidine kinase PET red fluorescent protein vascular cell adhesion protein 1 Preclinical severe combined immunodeficient Human epidermal growth factor receptor 2 platelet-derived growth factor receptor endothelial growth factor receptor vascular endothelial growth factor receptor

Related Topics

Physical Sciences and Engineering Materials Science Biomaterials

Preclinical imaging and translational animal models of cancer for accelerated clinical implementation of nanotechnologies and macromolecular agents

Authors

Raquel De Souza, Tara Spence, Huang Huang, Christine Allen,